Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

A global database of nitrogen and phosphorus excretion rates of aquatic animals.

Vanni MJ, McIntyre PB, Allen D, Arnott DL, Benstead JP, Berg DJ, Brabrand Å, Brosse S, Bukaveckas PA, Caliman A, Capps KA, Carneiro LS, Chadwick NE, Christian AD, Clarke A, Conroy JD, Cross WF, Culver DA, Dalton CM, Devine JA, Domine LM, Evans-White MA, Faafeng BA, Flecker AS, Gido KB, Godinot C, Guariento RD, Haertel-Borer S, Hall RO, Henry R, Herwig BR, Hicks BJ, Higgins KA, Hood JM, Hopton ME, Ikeda T, James WF, Jansen HM, Johnson CR, Koch BJ, Lamberti GA, Lessard-Pilon S, Maerz JC, Mather ME, McManamay RA, Milanovich JR, Morgan DKJ, Moslemi JM, Naddafi R, Nilssen JP, Pagano M, Pilati A, Post DM, Roopin M, Rugenski AT, Schaus MH, Shostell J, Small GE, Solomon CT, Sterrett SC, Strand Ø, Tarvainen M, Taylor JM, Torres-Gerald LE, Turner CB, Urabe J, Uye SI, Ventelä AM, Villeger S, Whiles MR, Wilhelm FM, Wilson HF, Xenopoulos MA, Zimmer KD.

Ecology. 2017 May;98(5):1475. doi: 10.1002/ecy.1792. Epub 2017 Apr 18.

2.

Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis.

van der Plas MN, van Kan C, Blumenthal J, Jansen HM, Wells AU, Bresser P.

Respirology. 2014 Feb;19(2):269-275. doi: 10.1111/resp.12206. Epub 2013 Nov 20.

3.

Seasonal variation in mineralization rates (C-N-P-Si) of mussel Mytilus edulis biodeposits.

Jansen HM, Verdegem MC, Strand O, Smaal AC.

Mar Biol. 2012;159(7):1567-1580. Epub 2012 May 13.

4.

Predictors of incorrect inhalation technique in patients with asthma or COPD: a study using a validated videotaped scoring method.

Rootmensen GN, van Keimpema AR, Jansen HM, de Haan RJ.

J Aerosol Med Pulm Drug Deliv. 2010 Oct;23(5):323-8. doi: 10.1089/jamp.2009.0785.

PMID:
20804428
5.

Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.

Daniels JM, Schoorl M, Snijders D, Knol DL, Lutter R, Jansen HM, Boersma WG.

Chest. 2010 Nov;138(5):1108-15. doi: 10.1378/chest.09-2927. Epub 2010 Jun 24.

PMID:
20576731
6.

Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.

Daniels JM, Snijders D, de Graaff CS, Vlaspolder F, Jansen HM, Boersma WG.

Am J Respir Crit Care Med. 2010 Jan 15;181(2):150-7. doi: 10.1164/rccm.200906-0837OC. Epub 2009 Oct 29.

PMID:
19875685
7.

Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial.

Behr J, Demedts M, Buhl R, Costabel U, Dekhuijzen RP, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Lankhorst I, Sardina M, Boissard G; IFIGENIA study group.

Respir Res. 2009 Oct 27;10:101. doi: 10.1186/1465-9921-10-101.

8.

Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease.

Daniels JM, de Graaff CS, Vlaspolder F, Snijders D, Jansen HM, Boersma WG.

Clin Microbiol Infect. 2010 Jun;16(6):583-8. doi: 10.1111/j.1469-0691.2009.02892.x. Epub 2009 Jul 20.

9.

Arginine deficiency augments inflammatory mediator production by airway epithelial cells in vitro.

Fan XY, van den Berg A, Snoek M, van der Flier LG, Smids B, Jansen HM, Liu RY, Lutter R.

Respir Res. 2009 Jul 3;10:62. doi: 10.1186/1465-9921-10-62.

10.

Associations between pre-employment immunologic and airway mucosal factors and the development of occupational allergy.

Krop EJ, Heederik DJ, Lutter R, de Meer G, Aalberse RC, Jansen HM, van der Zee JS.

J Allergy Clin Immunol. 2009 Mar;123(3):694-700, 700.e1-3. doi: 10.1016/j.jaci.2008.12.021. Epub 2009 Feb 7.

PMID:
19201013
11.

Long-term effects of budesonide on inflammatory status in COPD.

Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE.

COPD. 2008 Apr;5(2):97-104. doi: 10.1080/15412550801941000.

PMID:
18415808
12.

Reliability in the assessment of videotaped inhalation technique.

Rootmensen GN, van Keimpema AR, Looysen EE, van der Schaaf L, Jansen HM, de Haan RJ.

J Aerosol Med. 2007 Winter;20(4):429-33.

PMID:
18158715
13.

Interstitial lung disease as the first manifestation of systemic sclerosis.

van der Kamp R, Tak PP, Jansen HM, Bresser P.

Neth J Med. 2007 Nov;65(10):390-4.

14.

The effects of additional care by a pulmonary nurse for asthma and COPD patients at a respiratory outpatient clinic: results from a double blind, randomized clinical trial.

Rootmensen GN, van Keimpema AR, Looysen EE, van der Schaaf L, de Haan RJ, Jansen HM.

Patient Educ Couns. 2008 Feb;70(2):179-86. Epub 2007 Nov 26.

PMID:
18031971
15.

Repeatability of inflammatory parameters in induced sputum of COPD patients.

Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE.

COPD. 2007 Dec;4(4):321-9.

PMID:
18027159
16.

Characterization of CD4+ memory T cell responses directed against common respiratory pathogens in peripheral blood and lung.

de Bree GJ, Daniels H, Schilfgaarde Mv, Jansen HM, Out TA, van Lier RA, Jonkers RE.

J Infect Dis. 2007 Jun 1;195(11):1718-25. Epub 2007 Apr 16.

PMID:
17471443
17.

The influence of the AA 16 beta 2-adrenoceptor polymorphism on systemic and airway responses in asthma.

van Veen A, Weller FR, Wierenga EA, Jansen HM, Jonkers RE.

Pulm Pharmacol Ther. 2008;21(1):73-8. Epub 2006 Dec 29.

PMID:
17292646
18.

Embolization for hemoptysis in chronic thromboembolic pulmonary hypertension: report of two cases and a review of the literature.

Reesink HJ, van Delden OM, Kloek JJ, Jansen HM, Reekers JA, Bresser P.

Cardiovasc Intervent Radiol. 2007 Jan-Feb;30(1):136-9.

PMID:
17086459
19.

Salmeterol enhances pulmonary fibrinolysis in healthy volunteers.

Maris NA, de Vos AF, Bresser P, van der Zee JS, Jansen HM, Levi M, van der Poll T.

Crit Care Med. 2007 Jan;35(1):57-63.

PMID:
17080003
20.

Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin.

Maris NA, Dessing MC, de Vos AF, Bresser P, van der Zee JS, Jansen HM, Spek CA, van der Poll T.

Eur Respir J. 2006 Sep;28(3):622-6.

21.

Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension.

Reesink HJ, Meijer RC, Lutter R, Boomsma F, Jansen HM, Kloek JJ, Bresser P.

Circ J. 2006 Aug;70(8):1058-63.

22.

Inhalation of beta 2 agonists impairs the clearance of nontypable Haemophilus influenzae from the murine respiratory tract.

Maris NA, Florquin S, van't Veer C, de Vos AF, Buurman W, Jansen HM, van der Poll T.

Respir Res. 2006 Apr 4;7:57.

23.

Cytoskeletal architecture differentially controls post-transcriptional processing of IL-6 and IL-8 mRNA in airway epithelial-like cells.

van den Berg A, Freitas J, Keles F, Snoek M, van Marle J, Jansen HM, Lutter R.

Exp Cell Res. 2006 May 15;312(9):1496-506. Epub 2006 Feb 24.

PMID:
16499908
24.

IL-12 deficiency transiently improves viral clearance during the late phase of respiratory tract infection with influenza A virus in mice.

van der Sluijs KF, van Elden LJ, Xiao Y, Arens R, Nijhuis M, Schuurman R, Florquin S, Jansen HM, Lutter R, van der Poll T.

Antiviral Res. 2006 Jun;70(2):75-84. Epub 2006 Feb 9.

PMID:
16490265
25.

Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.

Koopmans JG, Lutter R, Jansen HM, van der Zee JS.

Thorax. 2006 Apr;61(4):306-12. Epub 2006 Jan 31.

26.

Limited beta2-adrenoceptor haplotypes display different agonist mediated airway responses in asthmatics.

van Veen A, Wierenga EA, Westland R, Weller FR, Hart GA, Jansen HM, Jonkers RE.

Respir Res. 2006 Jan 31;7:19.

27.

Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia.

van der Sluijs KF, Nijhuis M, Levels JH, Florquin S, Mellor AL, Jansen HM, van der Poll T, Lutter R.

J Infect Dis. 2006 Jan 15;193(2):214-22. Epub 2005 Dec 14.

PMID:
16362885
28.

High-dose acetylcysteine in idiopathic pulmonary fibrosis.

Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Capron F, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Corvasce G, Lankhorst I, Sardina M, Montanari M; IFIGENIA Study Group.

N Engl J Med. 2005 Nov 24;353(21):2229-42.

29.

Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung.

de Bree GJ, van Leeuwen EM, Out TA, Jansen HM, Jonkers RE, van Lier RA.

J Exp Med. 2005 Nov 21;202(10):1433-42.

30.

Clinically masked increases in bronchial inflammation in guideline-treated persistent asthma.

Koopmans JG, Lutter R, Jansen HM, van der Zee JS.

Pulm Pharmacol Ther. 2006;19(6):397-403. Epub 2005 Nov 18.

PMID:
16298535
31.

Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.

Koopmans JG, Lutter R, Jansen HM, van der Zee JS.

J Allergy Clin Immunol. 2005 Nov;116(5):1007-13. Epub 2005 Oct 3.

PMID:
16275368
32.

E1A expression dysregulates IL-8 production and suppresses IL-6 production by lung epithelial cells.

van den Berg A, Snoek M, Jansen HM, Lutter R.

Respir Res. 2005 Sep 26;6:111.

33.
34.

Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia.

van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Florquin S, Shimizu T, Ishii S, Jansen HM, Lutter R, van der Poll T.

Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L194-9. Epub 2005 Aug 12.

35.
36.

Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers.

Maris NA, de Vos AF, Dessing MC, Spek CA, Lutter R, Jansen HM, van der Zee JS, Bresser P, van der Poll T.

Am J Respir Crit Care Med. 2005 Oct 1;172(7):878-84. Epub 2005 Jun 30.

PMID:
15994467
37.

Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers.

Maris NA, de Vos AF, Bresser P, van der Zee JS, Meijers JC, Lijnen HR, Levi M, Jansen HM, van der Poll T.

Thromb Haemost. 2005 Jun;93(6):1036-40.

PMID:
15968385
38.

Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia.

van der Eerden MM, Vlaspolder F, de Graaff CS, Groot T, Jansen HM, Boersma WG.

Eur J Clin Microbiol Infect Dis. 2005 Apr;24(4):241-9.

PMID:
15902529
39.

Interleukin-17 induces hyperresponsive interleukin-8 and interleukin-6 production to tumor necrosis factor-alpha in structural lung cells.

van den Berg A, Kuiper M, Snoek M, Timens W, Postma DS, Jansen HM, Lutter R.

Am J Respir Cell Mol Biol. 2005 Jul;33(1):97-104. Epub 2005 Apr 21.

PMID:
15845864
40.

Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons.

de Bree GJ, Heidema J, van Leeuwen EM, van Bleek GM, Jonkers RE, Jansen HM, van Lier RA, Out TA.

J Infect Dis. 2005 May 15;191(10):1710-8. Epub 2005 Apr 11.

PMID:
15838799
41.

Serum surfactant protein D is elevated in allergic patients.

Koopmans JG, van der Zee JS, Krop EJ, Lopuhaä CE, Jansen HM, Batenburg JJ.

Clin Exp Allergy. 2004 Dec;34(12):1827-33.

PMID:
15663555
42.

Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus.

Van Der Sluijs KF, Van Elden LJ, Arens R, Nijhuis M, Schuurman R, Florquin S, Kwakkel J, Akira S, Jansen HM, Lutter R, Van Der Polls T.

Immunology. 2005 Jan;114(1):112-20.

43.

Limited impact of multiple 5' single-nucleotide polymorphisms on the transcriptional control of the human beta 2-adrenoceptor gene.

Westland R, van Veen A, Jansen HM, Jonkers RE, Wierenga EA.

Immunogenetics. 2004 Dec;56(9):625-30. Epub 2004 Nov 17.

PMID:
15578262
44.

Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumonia.

van der Eerden MM, de Graaff CS, Bronsveld W, Jansen HM, Boersma WG.

Respir Med. 2004 Sep;98(9):872-8.

45.

Exaggerated IL-8 and IL-6 responses to TNF-alpha by parainfluenza virus type 4-infected NCI-H292 cells.

Roger T, Bresser P, Snoek M, van der Sluijs K, van den Berg A, Nijhuis M, Jansen HM, Lutter R.

Am J Physiol Lung Cell Mol Physiol. 2004 Nov;287(5):L1048-55. Epub 2004 Jul 23.

46.

IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.

van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Pater JM, Florquin S, Goldman M, Jansen HM, Lutter R, van der Poll T.

J Immunol. 2004 Jun 15;172(12):7603-9.

47.

Evaluation of an algorithm for switching from IV to PO therapy in clinical practice in patients with community-acquired pneumonia.

van der Eerden MM, de Graaff CS, Vlaspolder F, Bronsveld W, Jansen HM, Boersma WG.

Clin Ther. 2004 Feb;26(2):294-303.

PMID:
15038952
48.

Abnormal radiological findings and a decreased carbon monoxide transfer factor can persist long after the acute phase of Legionella pneumophila pneumonia.

Jonkers RE, Lettinga KD, Pels Rijcken TH, Prins JM, Roos CM, van Delden OM, Verbon A, Bresser P, Jansen HM.

Clin Infect Dis. 2004 Mar 1;38(5):605-11. Epub 2004 Feb 17.

PMID:
14986242
49.

Salmeterol, a beta2-receptor agonist, attenuates lipopolysaccharide-induced lung inflammation in mice.

Maris NA, van der Sluijs KF, Florquin S, de Vos AF, Pater JM, Jansen HM, van der Poll T.

Am J Physiol Lung Cell Mol Physiol. 2004 Jun;286(6):L1122-8. Epub 2004 Jan 16.

50.

Enzyme-linked immunosorbent assays using immune complexes for the diagnosis of tuberculosis.

Pereira Arias-Bouda LM, Kuijper S, van Deutekom H, van Gijlswijk R, Pekel I, Jansen HM, Kolk AH.

J Immunol Methods. 2003 Dec;283(1-2):115-24.

PMID:
14659904

Supplemental Content

Loading ...
Support Center